N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143460 |
| CAS No | NA |
| Mol.F. | C13H13N3O4 |
| Mol.Wt. | 275.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143461 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O2 |
| Mol.Wt. | 275.69 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143462 |
| CAS No | NA |
| Mol.F. | C25H38N4O9 |
| Mol.Wt. | 538.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143463 |
| CAS No | NA |
| Mol.F. | C25H37N5O10 |
| Mol.Wt. | 567.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143464 |
| CAS No | NA |
| Mol.F. | C22H34N4O9 |
| Mol.Wt. | 498 .5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143465 |
| CAS No | NA |
| Mol.F. | C19H28N4O7 |
| Mol.Wt. | 424.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143466 |
| CAS No | 1026879-47-9 |
| Mol.F. | C27H33N3O8 |
| Mol.Wt. | 527.6 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143467 |
| CAS No | NA |
| Mol.F. | C7H6BrN5O3 |
| Mol.Wt. | 288.06 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143468 |
| CAS No | NA |
| Mol.F. | C6H4BrN5O3 |
| Mol.Wt. | 274.03 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143469 |
| CAS No | NA |
| Mol.F. | C4H10N2O2 |
| Mol.Wt. | 118.14 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143470 |
| CAS No | 943-41-9 |
| Mol.F. | C7H7N3O3 |
| Mol.Wt. | 181.15 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143471 |
| CAS No | NA |
| Mol.F. | C19H28N4O7 |
| Mol.Wt. | 424.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143472 |
| CAS No | NA |
| Mol.F. | C7H12N4O3 |
| Mol.Wt. | 200.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143473 |
| CAS No | NA |
| Mol.F. | C25H36N4O9 |
| Mol.Wt. | 536.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143474 |
| CAS No | NA |
| Mol.F. | C20H31N3O7 |
| Mol.Wt. | 425.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143475 |
| CAS No | NA |
| Mol.F. | C13H17N5O7S |
| Mol.Wt. | 387.37g/mole |
| INV STATUS | CUSTOM SYNTHESIS |